Credit Ratings
CETUS Corp. (Emeryville, Calif.) -- Moody's Investor's
Service Inc. raised its rating on this biotechnology
concern's 5.25% convertible subordinated Eurobonds to
single-B-1 from single-B-3, affecting about $100 million of
long-term debt. The rating agency said the upgrade was
prompted by the company's improved prospects following its
recent acquisition by Chiron Corp.